New Pathways Clinic believes that patients will receive the best care if we work in tandem. Our Medical Director, Dr. Ryan O’Neill, completed medical school and emergency medicine residency at The Ohio State University, and currently works as an emergency medicine attending in Columbus, OH. Throughout his training and practice, he has had extensive experience working with ketamine in the clinical setting, and believes it can be a powerful tool in the management of one’s mental health. His mission is to ensure safe and effective treatment for our patients at all of our clinical sites.
Below is everything you need to know about Ketamine treatments and our referral process.
According to the CDC, the suicide rate in the USA has been steadily climbing since 1999. Suicide rates increased 33% between 1999 and 2019 and Suicide is now the 10th leading cause of death. It was responsible for more than 47,500 deaths in 2019.
Researchers have implicated the increase in depression and PTSD as causally related. Ketamine is an invaluable tool to fight Treatment Resistant Depression, PTSD, and suicidal ideation. Other studies from respected institutions such as Columbia University, Yale, the National Institutes of Mental Health, and the Department of Defense, have demonstrated the efficacy of low-dose ketamine infusions to effectively treat these conditions:
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial (Columbia University)
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics (Yale University)
Rapid Antidepressant Effects of Ketamine in Major Depression (National Institute of Mental Health)
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD) (Mt. Sinai and Department of Defense)
To begin treatment for your patient, we will need patient identifying information, as well as relevant medical records. To start this process, please fill out our Electronic Patient Referral or download and fax us the Referring Provider Form at 440-201-6400. Alternatively, you can always contact New Pathways Clinic at 440–973–8400 or [email protected].
New Pathways Clinic provides evidence-based solutions for mental health, in accordance with the most recent science in the field. Our primary treatment of low-dose ketamine infusions is effective in relieving symptoms of Treatment Resistant Depression (TRD), PTSD, Bipolar Disorder, and Anxiety.
Our policies and procedures were developed based on first-hand participation in Cleveland Clinic’s ketamine infusion research that was ongoing for over 10 years. Our patients’ evidence-based improvements are reported to you upon request.
Our goal at New Pathways Clinic is to offer an adjunct therapy to the treatment you are already providing your patient. We want to collaborate with you to provide the most effective treatments available for your patients.
Our screening protocols include relevant mental health scales, substance abuse screening, medical history assessment, pregnancy tests for women who are in child-bearing years, and blood tests when necessary. As part of this screening process, clarification of past psychotropic treatments and responses will be also be obtained.
Once clinical appropriateness is determined, ketamine infusion treatment will involve a sub-anesthetic dose given slowly, monitored continuously by RN’s, and built around the best practices set forth by the American Psychiatric Association.
Please see our Ketamine Research Portal for more studies and information. We will continue to keep it updated as dozens of large and exciting trials from venerated institutions in the USA and around the world are ongoing!